Lawmakers Hear the Down Side of Outcomes-Based Pricing

Drug Industry Daily
A A
Outcomes-based contracting may not help reduce drug prices, one witness cautioned lawmakers in a House Ways and Means subcommittee hearing on Thursday.

To View This Article:

Login

Subscribe To Drug Industry Daily